| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784829 | Advances in Radiation Oncology | 2018 | 8 Pages |
Abstract
Overall, Grade â¥2 AE rates of thoracic RT and immunotherapy appeared as expected and acceptable. The lack of significant differences in AE rates with concurrent versus sequential treatment suggests that even concurrent immunotherapy and thoracic RT may be safe.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Donata BS, Jamie E. MD, Abraham J. MD, Robert MD, PhD, Matthew D. MD, Andrew J. MD, Zhigang PhD, Weiji MS, Rosalind BS, Kelly H. BA, Christopher A. MD, Andreas MD,